Sleep disorders as core symptoms of depression D Nutt, S Wilson, L Paterson Dialogues in clinical neuroscience 10 (3), 329-336, 2008 | 1023 | 2008 |
5‐HT radioligands for human brain imaging with PET and SPECT LM Paterson, BR Kornum, DJ Nutt, VW Pike, GM Knudsen Medicinal research reviews 33 (1), 54-111, 2013 | 176 | 2013 |
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls LM Paterson, RJ Tyacke, DJ Nutt, GM Knudsen Journal of Cerebral Blood Flow & Metabolism 30 (10), 1682-1706, 2010 | 167 | 2010 |
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement R Agabio, JMA Sinclair, G Addolorato, HJ Aubin, EM Beraha, F Caputo, ... The Lancet Psychiatry 5 (12), 957-960, 2018 | 128 | 2018 |
The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective R De Beaurepaire, JMA Sinclair, M Heydtmann, G Addolorato, HJ Aubin, ... Frontiers in psychiatry 9, 708, 2019 | 88 | 2019 |
Antidepressants and REM sleep in Wistar–Kyoto and Sprague–Dawley rats M Ivarsson, LM Paterson, PH Hutson European journal of pharmacology 522 (1-3), 63-71, 2005 | 86 | 2005 |
Alcohol and the Brain D Nutt, A Hayes, L Fonville, R Zafar, EOC Palmer, L Paterson, ... Nutrients 13 (11), 3938, 2021 | 85 | 2021 |
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers LM Paterson, SJ Wilson, DJ Nutt, PH Hutson, M Ivarsson Psychopharmacology 191 (4), 943-950, 2007 | 64 | 2007 |
Acute D3 antagonist GSK598809 selectively enhances neural response during monetary reward anticipation in drug and alcohol dependence A Murphy, LJ Nestor, J McGonigle, L Paterson, V Boyapati, KD Ersche, ... Neuropsychopharmacology 42 (5), 1049-1057, 2017 | 52 | 2017 |
The Imperial College Cambridge Manchester (ICCAM) platform study: an experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: study … LM Paterson, RSA Flechais, A Murphy, LJ Reed, S Abbott, V Boyapati, ... Journal of Psychopharmacology 29 (9), 943-960, 2015 | 49 | 2015 |
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approach EM Taylor, A Murphy, V Boyapati, KD Ersche, R Flechais, S Kuchibatla, ... Psychopharmacology 233 (8), 1487-1499, 2016 | 42 | 2016 |
Acute naltrexone does not remediate fronto‐striatal disturbances in alcoholic and alcoholic polysubstance‐dependent populations during a monetary incentive delay task LJ Nestor, A Murphy, J McGonigle, C Orban, L Reed, E Taylor, R Flechais, ... Addiction biology 22 (6), 1576-1589, 2017 | 41 | 2017 |
Sleep and its disorders in translational medicine LM Paterson, DJ Nutt, SJ Wilson Journal of psychopharmacology 25 (9), 1226-1234, 2011 | 41 | 2011 |
Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption LM Paterson, SJ Wilson, DJ Nutt, PH Hutson, M Ivarsson Journal of Psychopharmacology 23 (5), 475-486, 2009 | 38 | 2009 |
Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers LM Paterson, DJ Nutt, M Ivarsson, PH Hutson, SJ Wilson Journal of Psychopharmacology 23 (5), 487-494, 2009 | 38 | 2009 |
NAPSAQ-1: national patient sleep assessment questionnaire in depression LM Paterson, DJ Nutt, SJ Wilson International journal of psychiatry in clinical practice 13 (1), 48-58, 2009 | 37 | 2009 |
Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals LS Morris, K Baek, R Tait, R Elliott, KD Ersche, R Flechais, J McGonigle, ... Addiction biology 23 (1), 425-436, 2018 | 34 | 2018 |
The neurobiology of substance use and addiction: evidence from neuroimaging and relevance to treatment A Hayes, K Herlinger, L Paterson, A Lingford-Hughes BJPsych Advances 26 (6), 367-378, 2020 | 33 | 2020 |
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery G Savulich, R Riccelli, L Passamonti, M Correia, JFW Deakin, R Elliott, ... Translational psychiatry 7 (3), e1054-e1054, 2017 | 25 | 2017 |
Using baclofen to explore GABA-B receptor function in alcohol dependence: insights from pharmacokinetic and pharmacodynamic measures CF Durant, LM Paterson, S Turton, SJ Wilson, JFM Myers, ... Frontiers in Psychiatry 9, 664, 2018 | 24 | 2018 |